Carla Colaci

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Positive Breast Cancer

Radical Prostatectomy

Epidermal Growth Factor Receptor

Top Venues

PharmacoEconomics - open

Revista peruana de medicina experimental y salud publica

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open 8 (5) (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open 8 (5) (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open 8 (5) (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open (2024)
Agustín Ciapponi, Ariel Esteban Bardach, Carla Colaci, Federico Rodriguez Cairoli, Fernando J Argento, Ernesto Korbenfeld, Sebastian Garcia Marti
Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER-2 positive breast cancer: systematic review and network meta-analysis. Revista peruana de medicina experimental y salud publica 41 (1) (2024)
Agustín Ciapponi, Ariel Esteban Bardach, Carla Colaci, Federico Rodriguez Cairoli, Fernando J Argento, Ernesto Korbenfeld, Sebastian Garcia Marti
Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER-2 positive breast cancer: systematic review and network meta-analysis. Revista peruana de medicina experimental y salud publica 41 (1) (2024)
Agustín Ciapponi, Ariel Esteban Bardach, Carla Colaci, Federico Rodriguez Cairoli, Fernando J Argento, Ernesto Korbenfeld, Sebastian Garcia Marti
Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER-2 positive breast cancer: systematic review and network meta-analysis. Revista peruana de medicina experimental y salud publica 41 (1) (2024)